Atlas Trials

Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

Clinical trial NCT05943535 · RECRUITING

Trial details

NCT number
NCT05943535
Sponsor
United Therapeutics
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Progressive Pulmonary FibrosisInterstitial Lung Disease
Start date
2023-10-30
Primary completion
2027-11-01
Enrollment
698

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.